Literature DB >> 3277248

Imaging of the aging brain. Part II. Pathologic conditions.

B P Drayer1.   

Abstract

The most common pathologic disorders in the elderly result in dementia, movement disorders, and/or focal neurologic deficit. Neuroimaging, particularly magnetic resonance (MR), provides a unique window into the diagnosis and understanding of such diseases. The most common cause of dementing illness is Alzheimer disease (enlarged cerebrospinal fluid spaces, focal medial temporal lobe abnormal signal intensity, cortical iron). Since the initiation of MR imaging, important questions are being asked about the role of white matter disease (signal hyperintensities) in primary degenerative dementia and the nosology of vascular dementia. Parkinsonian disorders are characterized by generalized brain atrophy and dopaminergic site (e.g., putamen, pars compacta of the substantia nigra) iron or pigmentary accumulation best visualized in disease that responds poorly to dopamine replacement therapy. A key role of imaging in the elderly is the noninvasive exclusion of mass lesion (e.g., hematoma, neoplasm). MR imaging is exquisitely sensitive for the detection of the two common abnormalities that cause focal neurologic deficit in the elderly--infarction and intracerebral hematoma.

Entities:  

Mesh:

Year:  1988        PMID: 3277248     DOI: 10.1148/radiology.166.3.3277248

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  19 in total

1.  Neurological long term consequences of deep diving.

Authors:  K Todnem; H Nyland; H Skeidsvoll; R Svihus; P Rinck; B K Kambestad; T Riise; J A Aarli
Journal:  Br J Ind Med       Date:  1991-04

2.  Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system.

Authors:  M Eapen; D H Zald; J C Gatenby; Z Ding; J C Gore
Journal:  AJNR Am J Neuroradiol       Date:  2010-12-23       Impact factor: 3.825

Review 3.  Nuclear magnetic resonance in clinical pharmacology and measurement of therapeutic response.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

Review 4.  The blood-brain barrier and selective vulnerability in experimental thiamine-deficiency encephalopathy in the mouse.

Authors:  N Harata; Y Iwasaki
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

5.  Motor cortex hypointensity on susceptibility-weighted imaging: a potential imaging marker of iron accumulation in patients with cognitive impairment.

Authors:  Mina Park; Yeonsil Moon; Seol-Heui Han; Won-Jin Moon
Journal:  Neuroradiology       Date:  2019-01-28       Impact factor: 2.804

6.  Magnetic resonance imaging of monocytes labeled with ultrasmall superparamagnetic particles of iron oxide using magnetoelectroporation in an animal model of multiple sclerosis.

Authors:  Raoul D Oude Engberink; Susanne M A van der Pol; Pjotr Walczak; Annette van der Toorn; Max A Viergever; Christine D Dijkstra; Jeff W M Bulte; Helga E de Vries; Erwin L A Blezer
Journal:  Mol Imaging       Date:  2010-10       Impact factor: 4.488

7.  Mineralization of the deep gray matter with age: a retrospective review with susceptibility-weighted MR imaging.

Authors:  S L Harder; K M Hopp; H Ward; H Neglio; J Gitlin; D Kido
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-07       Impact factor: 3.825

8.  Evaluation of investigations to diagnose the cause of dizziness in elderly people: a community based controlled study.

Authors:  N R Colledge; R M Barr-Hamilton; S J Lewis; R J Sellar; J A Wilson
Journal:  BMJ       Date:  1996-09-28

9.  Periventricular hyperintensity on magnetic resonance imaging correlated with brain ageing and atrophy.

Authors:  K Meguro; T Yamaguchi; T Hishinuma; H Miyazawa; S Ono; K Yamada; T Matsuzawa
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

10.  MRI and pathological examination of post-mortem brains: the problem of white matter high signal areas.

Authors:  M Scarpelli; U Salvolini; L Diamanti; R Montironi; L Chiaromoni; M Maricotti
Journal:  Neuroradiology       Date:  1994-07       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.